We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Blinatumomab is associated with favorable outcomes in patients with B‐cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10<sup>−4</sup> and higher.
- Authors
Jabbour, Elias J.; Short, Nicholas J.; Jain, Nitin; Jammal, Nadya; Jorgensen, Jeffrey; Wang, Sa; Wang, Xuemei; Ohanian, Maro; Alvarado, Yesid; Kadia, Tapan; Sasaki, Koji; Garris, Rebecca; Garcia‐Manero, Guillermo; Ravandi, Farhad; Kantarjian, Hagop M.
- Publication
American Journal of Hematology, 2022, Vol 97, Issue 9, p1135
- ISSN
0361-8609
- Publication type
Article
- DOI
10.1002/ajh.26634